Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI)
- PMID: 15312856
- DOI: 10.1016/j.jacc.2004.05.041
Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI)
Abstract
Objectives: Coronary angiograms obtained five years following revascularization were examined to assess the extent of compromise in myocardial perfusion due to failure of revascularization versus progression of native disease.
Background: The Bypass Angioplasty Revascularization Investigation (BARI) randomized revascularization candidates between bypass surgery and angioplasty. Entry and five-year angiograms from 407 of 519 (78%) patients at four centers were analyzed.
Methods: Analysis of the distribution of coronary vessels and stenoses provided a measure of myocardial jeopardy that correlates with presence of angina. The extent to which initial benefits of revascularization were undone by failed revascularization versus native disease progression was assessed.
Results: Myocardial jeopardy fell following initial revascularization, from 60% to 17% for percutaneous coronary intervention (PCI)-treated patients compared with 60% to 7% for coronary artery bypass graft (CABG) surgery patients (p < 0.001), rebounding at five years to 25% for PCI and 20% for surgery patients (p = 0.01). Correspondingly, angina prevalence was higher at five years in PCI-treated patients than in surgery-treated patients (28% vs. 18%; p = 0.03). However, myocardial jeopardy at five years, and not initial treatment (PCI vs. surgery), was independently associated with late angina. Increased myocardial jeopardy from entry to five-year angiogram occurred in 42% of PCI-treated patients and 51% of CABG-treated patients (p = 0.06). Among the increases in myocardial jeopardy, two-thirds occurred in previously untreated arteries.
Conclusions: Native coronary disease progression occurred more often than failed revascularization in both PCI- and CABG-treated patients as a cause of jeopardized myocardium and angina recurrence. These results support intensive postrevascularization risk-factor modification.
Comment in
-
Did we enjoy the debate but forget the patient?J Am Coll Cardiol. 2004 Aug 18;44(4):775-7. doi: 10.1016/j.jacc.2004.05.043. J Am Coll Cardiol. 2004. PMID: 15312857 No abstract available.
Similar articles
-
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI).J Am Coll Cardiol. 1999 Nov 15;34(6):1750-9. doi: 10.1016/s0735-1097(99)00406-4. J Am Coll Cardiol. 1999. PMID: 10577566 Clinical Trial.
-
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.Circ Cardiovasc Qual Outcomes. 2012 May;5(3):267-75. doi: 10.1161/CIRCOUTCOMES.111.964585. Epub 2012 Apr 10. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22496114 Clinical Trial.
-
Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).Am J Cardiol. 2009 Mar 1;103(5):632-8. doi: 10.1016/j.amjcard.2008.11.024. Epub 2009 Jan 12. Am J Cardiol. 2009. PMID: 19231325 Clinical Trial.
-
Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.Minerva Cardioangiol. 2003 Oct;51(5):585-97. Minerva Cardioangiol. 2003. PMID: 14551526 Review.
-
Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery.JACC Cardiovasc Interv. 2008 Oct;1(5):483-91. doi: 10.1016/j.jcin.2008.07.001. JACC Cardiovasc Interv. 2008. PMID: 19463349 Review.
Cited by
-
Bifurcation functional significance score as predictor of mortality: a validating study.Sci Rep. 2021 Dec 21;11(1):24308. doi: 10.1038/s41598-021-03815-6. Sci Rep. 2021. PMID: 34934122 Free PMC article.
-
The risk for subsequent coronary interventions in a local Polish population.Postepy Kardiol Interwencyjnej. 2020 Dec;16(4):429-435. doi: 10.5114/aic.2020.101768. Epub 2020 Dec 29. Postepy Kardiol Interwencyjnej. 2020. PMID: 33598016 Free PMC article.
-
Cardiac Computed Tomography in Monitoring Revascularization.J Clin Med. 2023 Nov 15;12(22):7104. doi: 10.3390/jcm12227104. J Clin Med. 2023. PMID: 38002715 Free PMC article. Review.
-
The Prognostic Value and Clinical Use of Myocardial Perfusion Scintigraphy in Asymptomatic Patients after Percutaneous Coronary Intervention.Arq Bras Cardiol. 2018 Dec;111(6):784-793. doi: 10.5935/abc.20180199. Arq Bras Cardiol. 2018. PMID: 30517374 Free PMC article.
-
An Aggregate Biomarker Risk Score Predicts High Risk of Near-Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes).J Am Heart Assoc. 2017 Jul 3;6(7):e003587. doi: 10.1161/JAHA.116.003587. J Am Heart Assoc. 2017. PMID: 28673897 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous